Portal Innovations announced that Grove Biopharma has successfully closed an oversubscribed $4 million seed round and will become a portfolio member at its Fulton Labs location. Other participants in the financing include Joe Mansueto, Skydeck Capital, and Walder Ventures.

Grove is a platform biotech company, spinning out of Northwestern University, pioneering the discovery and development of an innovative proteomimetic therapeutic modality. Grove Biopharma's materials science solution to peptide therapeutic challenges, are focused on the discovery and development of a novel class of 'protein-like polymers' to treat significant unmet medical needs in chronic inflammatory and neurodegenerative diseases.